Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last A$0.08 AUD
Change Today 0.00 / 0.00%
Volume 0.0
ACL On Other Exchanges
As of 1:10 AM 10/13/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by ALCHEMIA LTD (ACL) in the last 6 months

Announced 09/25/15
18.00M for Alchemia Limited, Worldwide Exclusive Intellectual Property Rights of Fondaparinux Sodium

Dr. Reddy's Laboratories Ltd. (BSE:500124) entered into a binding term sheet to acquire worldwide exclusive intellectual property rights of fondaparinux sodium from Alchemia Limited (ASX:ACL) for $17.5 million in cash on September 25, 2015. For the period ended June 30, 2015, Fondaparinux had revenues of $6.23 million, loss after tax of $6.22 million, total assets of $7.8 million. The sale is conditional on shareholder approval of Alchemia Limited. Shareholder approval ...
Read More

ACL's price was unchanged after the transaction was announced on 09/25/15.
Investor / Buyer
Dr. Reddy's Laboratories Ltd.
Creditor / Lender
Alchemia Limited
Announced 07/1/15
16.00M for Audeo Oncology, Inc.

Panther Biotechnology, Inc. (OTCPK:PBYA) executed a binding term sheet to acquire Audeo Oncology, Inc. from Alchemia Limited (ASX:ACL) for $16 million in stock and milestone payments on July 1, 2015. Under the terms of the transaction, Panther will pay stock of $15 million, upon a successful listing of Panther on NASDAQ and $1 million cash milestone payment to Alchemia on commencement of a Phase III clinical trial and royalties on world-wide net sales of HyACT products. ...
Read More

ACL's price was unchanged after the transaction was announced on 07/1/15.
Investor / Buyer
Panther Biotechnology, Inc.
Creditor / Lender
Alchemia Limited

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACL:AU A$0.08 AUD 0.00

ACL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ACL.
View Industry Companies

Industry Analysis


Industry Average

Valuation ACL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 2.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALCHEMIA LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at